Supplementary Figure 12 from Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma

Supplementary Figure S12 outlines the flow cytometry strategy used for T-cell persistence analysis. This figure includes representative flow cytometry plots of human CD45 expression in mouse blood samples from tumor-bearing mice, detailing negative controls, untransduced (UTD) T-cell controls, and BCMA CAR T-cell controls. Additionally, it displays representative dot plots of CAR expression on the surface of T cells prior to infusion.